Balstilimab + evofosfamide + zalifrelimab

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Balstilimab + evofosfamide + zalifrelimab
Treatment and conditionWhere it standsTrials
Balstilimab + evofosfamide + zalifrelimab for prostatic neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Balstilimab + evofosfamide + zalifrelimab for squamous cell carcinoma of head and neckPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1